122 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:19pm
, suspensions or termination of clinical trials by the applicable institutional review board or independent ethics board responsible for overseeing the study …
The Company’s management is responsible for the presentation and preparation of the financial statements and the MD&A. The MD&A have been prepared
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
information for commercial advantage, personal gain, or malicious harm. The U.S. Department of Justice is responsible for criminal prosecutions under HIPAA … -Canadian must file an application for review with the Minister responsible for the Investment Canada Act (Canada) and obtain approval of the Minister prior
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:17pm
the Manager be responsible for any amount in excess of the Broker Fee applicable to the Shares and paid hereunder. This indemnity agreement … the indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel retained by the indemnified party
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:15pm
responsible for overseeing the study to protect research subjects; delays in identifying and reaching agreement on acceptable terms with prospective clinical … operating results or financial condition.
MANAGEMENT’S RESPONSIBILITY FOR FINANCIAL STATEMENTS
The Company’s management is responsible
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:12pm
, suspensions or termination of clinical trials by the applicable institutional review board or independent ethics board responsible for overseeing the study …
The Company’s management is responsible for the presentation and preparation of the financial statements and the MD&A. The MD&A have been prepared
424B3
rtvwro8kk09 z9h
13 Jun 24
Prospectus supplement
4:11pm
424B3
mm9jtl041dr4r4
13 Jun 24
Prospectus supplement
4:10pm
424B3
vki0mzaq84n1qr
13 Jun 24
Prospectus supplement
4:10pm
6-K
EX-99.2
v8lybennhk5 ss
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-99.4
us1msfi 0sw9ic
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-99.3
bew76a8vpdr3si
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-10.1
4gnqf8j 0bustxwmi
30 Nov 23
XORTX Announces US ATM Offering
4:04pm
6-K
EX-99.4
t6ov2xnfc4
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm
6-K
EX-99.2
bv2 fcvkid07
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm